On your lab requisition: Quest “Galleri(R) (Performed/ Billed By Grail)” (test code 13731)
The short answer
Galleri Multi-Cancer Early Detection Test measures Cell-Free DNA Methylation Patterns, Cancer Signal Detection and Cancer Signal Origin from a standard blood draw. At TestWell it costs $799.99 plus a $6 lab processing fee, needs no fasting, and results post in 10–14 business days. Physician-authorized with no doctor's visit or insurance needed; draw at Quest.
Hospital Lab
$1200
cash pay
Other Labs
$949
+ lab fees
TestWell
$799.99
+ $6 lab processing fee
Often ordered together
Testosterone, Total
$33.49
Lithium Level
$29.00
Comprehensive Metabolic Panel
$20.49
The Galleri test by GRAIL uses next-generation sequencing to detect cell-free DNA (cfDNA) shed by cancer cells into the bloodstream. It can identify a shared cancer signal across more than 50 cancer types — including pancreatic, ovarian, liver, esophageal, and other cancers that currently have no recommended screening tests. When a cancer signal is detected, the test also predicts the tissue of origin to guide follow-up diagnostic workup. The Galleri test is intended as a complement to, not a replacement for, standard-of-care screenings like mammography, colonoscopy, and PSA. It is recommended for adults aged 50+ or those with elevated cancer risk. In clinical studies, the test demonstrated a low false-positive rate (0.5%) and detected cancers across all stages, though sensitivity is higher for later-stage cancers. A negative result does not rule out cancer. This is a premium screening test performed and billed by GRAIL, Inc.
Multi-cancer early detection (MCED) blood test from GRAIL that detects circulating tumor DNA fragments from 50+ cancer types — most of which have no standard screening (pancreatic, ovarian, esophageal, stomach, head/neck).
Adults 50+ (per GRAIL labeling) or younger adults with family history, BRCA/Lynch syndromes, or known cancer risk factors. Best used in addition to (not replacing) standard screening like mammogram, colonoscopy, and Pap.
Sample Type
Blood draw
Fasting
Not required
Results In
10–14 business days · typical; varies by lab and draw day
Performed At
Quest
3 biomarkers tested
Your Galleri Multi-Cancer Early Detection Test results will include values for each of the 3 biomarkers tested, along with reference ranges. Results are reviewed by a licensed physician before being released to your secure portal.
If any values fall outside the normal range, your report will include guidance on what that may mean and recommended next steps. You'll receive an email notification when your results are ready, typically within 10–14 business days.
Typical reference range layout
Lab reports show where your value sits relative to established reference intervals—your physician interprets this in context for you. Already have results? Analyze them with your AI assistant against our physician-reviewed ranges.
No fasting required. Drawn at a Quest patient service center into GRAIL's own collection tubes and sent to GRAIL's lab; Galleri must be ordered on its own (not with other tests), for adults 22+ who are not pregnant. Not available in Arizona, New York, New Jersey or Rhode Island. Results are reviewed by a licensed physician before release; if a cancer signal is detected, a physician contacts you directly to arrange follow-up.
Before paying you'll confirm: I confirm I am 22 or older and not pregnant, and I understand Galleri is intended for adults 50+ or at elevated risk of cancer. Galleri (GRAIL) is a screening test, not a diagnosis. It is intended for adults 50 and older, or adults with an elevated risk of cancer, as a complement to — not a replacement for — routine screenings such as mammography and colonoscopy. It is not validated in pregnancy or under age 22. A "Cancer Signal Detected" result is not a cancer diagnosis: a physician from our lab partner's network will contact you to arrange diagnostic follow-up (included in the price). A "No Cancer Signal Detected" result does not rule out cancer.
TestWell orders the same Galleri Multi-Cancer Early Detection Test the labs run for doctors' offices, so you can walk into Quest Diagnostics with our requisition — no doctor's visit, a licensed physician authorizes the order, and most patient service centers take walk-ins. The table shows each lab's own test code, the name printed on the requisition, what the lab charges on its own consumer site, and the price through TestWell at that lab (plus one $6 fee per order).
| Lab | Test code | On the requisition | Lab's own site | Through TestWell |
|---|---|---|---|---|
| Quest Diagnostics | test code 13731 | “Galleri(R) (Performed/ Billed By Grail)” | not sold direct | $799.99 + $6 |
You choose the lab at checkout; the requisition is written for that lab and arrives by email within minutes.Lab-direct prices are read from the labs' public pages and re-checked regularly.
Where to get it near you: patient service centers by state and city · search by ZIP code
A Galleri Multi-Cancer Early Detection Test costs $799.99 at TestWell — $805.99 all-in, since the $6 lab processing fee is charged once per order and there is no draw or physician fee. Hospital outpatient labs typically bill around $1200.00 self-pay. With insurance you pay your plan's negotiated rate against your deductible; TestWell's price is fixed before the draw and HSA/FSA-eligible. Full cost breakdown →
| Where you order | Price | One test, all-in | Notes |
|---|---|---|---|
| TestWell (drawn at Quest) | $799.99 | $805.99 | Includes the one $6 lab processing fee, charged once per order |
| Hospital outpatient lab, self-pay (typical) | $1200.00 | $1200.00 | Reference figure; hospital charges vary widely by facility and are often higher |
Lab test codes: Quest test code 13731. Competitor prices are read from the linked public pages and re-checked regularly; the labs' sites may add taxes or change prices without notice.
Compare more: Quest Diagnostics price list · Labcorp price list · Quest vs Labcorp · Lab test price checker
Per GRAIL's PATHFINDER and CCGA-3 studies: specificity 99.5% (low false-positive rate), but sensitivity varies by cancer stage — ~17% for stage 1, ~76% for stage 4. It's most useful as a complement to standard screening, not a replacement.
TestWell charges $799.99 — vs $949 retail direct from GRAIL. Insurance does not cover it. HSA/FSA reimbursement is at the plan's discretion.
No fasting required. The blood draw is a standard tube of blood shipped to GRAIL's CLIA-certified lab.
A positive result includes a 'cancer signal origin' prediction (e.g., 'GI', 'hematologic', 'head/neck'). Your clinician orders targeted imaging or biopsy based on that prediction. Galleri itself doesn't diagnose cancer — it triggers a workup.
No — Galleri's sensitivity for early colorectal cancer is much lower than colonoscopy. It complements traditional screening. Continue colonoscopy, mammogram, Pap, lung CT (if smoking history) on standard schedules.
Galleri is offered as a Laboratory Developed Test under CLIA. The FDA has granted Breakthrough Device designation but it is not yet FDA-approved as a screening device.
Galleri Multi-Cancer Early Detection Test results are typically ready in 10–14 business days after your draw at Quest. TestWell emails you the moment they post, and your results dashboard shows each marker against its reference range with a plain-English explanation.
Order the Galleri Multi-Cancer Early Detection Test online from TestWell for $799.99 (plus a $6 per-order lab processing fee) — no doctor's visit, referral or insurance needed. A licensed physician authorizes the order, then you walk into any Quest patient service center near you for the draw (the lab locator on our site lists the closest ones by ZIP code), and results arrive in 10–14 business days.
Yes. Laboratory tests are a qualified medical expense under IRS Publication 502, so the Galleri Multi-Cancer Early Detection Test ($799.99 plus the $6 per-order lab fee) can be paid with an HSA or FSA debit card at checkout, or reimbursed from the itemized receipt in your TestWell account. For a health FSA the expense counts on the day your blood is drawn, which matters at the December 31 plan-year deadline.
The Galleri Multi-Cancer Early Detection Test is Quest Diagnostics test code 13731 ("Galleri(R) (Performed/ Billed By Grail)"). TestWell sells it for $799.99 at Quest — no doctor's visit or insurance required, results in 10–14 business days. Codes verified against the labs' catalogs in 2026.
Medically reviewed by Youmna DiStefano, MD · Last reviewed September 2026
TestWell Price
$799.99
+ $6 lab processing fee at checkout
Often ordered together
Testosterone, Total
$33.49
Lithium Level
$29.00
Comprehensive Metabolic Panel
$20.49
No insurance needed · HIPAA compliant
Frequently ordered together
Customers who ordered Galleri Multi-Cancer Early Detection Test also added these for a more complete health picture.
Not sure where to start?
Galleri Multi-Cancer Early Detection Test
$799.99